Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
9.28
-1.07 (-10.34%)
At close: Feb 21, 2025, 4:00 PM
9.27
-0.01 (-0.11%)
After-hours: Feb 21, 2025, 7:59 PM EST
Recursion Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$8.75
Upside
-5.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Feb 6, 2025 |
| Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +7.76% | Jan 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +18.53% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +18.53% | Sep 4, 2024 |
| Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | -35.34% | Sep 3, 2024 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | -13.79% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +72.41% | Aug 9, 2024 |
| Keybanc | Keybanc | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +29.31% | Jul 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +83.19% | Jun 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +83.19% | May 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +83.19% | Apr 9, 2024 |
| Keybanc | Keybanc | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +72.41% | Mar 4, 2024 |
| Needham | Needham | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +83.19% | Feb 28, 2024 |
| TD Cowen | TD Cowen | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jan 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.